Source: Eur Respir J 2013; 41: 474-477



Rating:

Share or cite this content

Citations should be made in the following way:
Watanabe Satoshi, Waseda Yuko, Takato Hazuki, Inuzuka Kanako, Katayama Nobuyuki, Kasahara Kazuo, Fujimura Masaki. Influenza vaccine-induced interstitial lung disease. Eur Respir J 2013; 41: 474-477

Member's Comments

No comment yet.

Related content which might interest you: Influenza vaccine-induced ILD Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Role of influenza virus infection in lung fibrosis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Influenza and co-infections of the lung Source: International Congress 2014 – ERS/Lancet and Lancet Respiratory Medicine joint session: complicating infections in respiratory disease and critical care Year: 2014 Humoral immunodeficiency and the lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=220 Year: 2005 Response to subunit influenza vaccine in lung disease due to Wegener‘s granulomatosis Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Autoantibodies in interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection Source: Eur Respir Rev, 30 (162) 210194; 10.1183/16000617.0194-2021 Year: 2021 Pulmonary diseases in primary immunodeficiency syndromes Source: Respipedia Article Year: 2017 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 Antibody response to influenza vaccine in patients with sarcoidosis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Influenza vaccination in COPD Source: International Congress 2019 – Vaccines against respiratory infections Year: 2019 Humoral immune response to influenza vaccination in silicosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 695s Year: 2006 Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Interstitial lung disease in common variable immunodeficiency associated granulomatous disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Severe influenza virus H1N1: Lung pathology Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010